Celanese Corporation (NYSE:CE), a global hybrid chemical company, today announced that it completed the sale of its oxo products and derivatives businesses, including European Oxo GmbH (“EOXO”), a joint venture between Celanese AG and Degussa AG, to Advent International, for the purchase price of EUR€480 million, which is approximately USD $630 million at current exchange rates. The transaction excludes limited business activity in Turkey, which remains subject to customary regulatory review. Celanese announced its agreement to sell these businesses in December 2006.
“This sale is consistent with Celanese’s strategy to divest non-core businesses and to increase focus on our core acetyl chain and downstream specialty businesses,” said David Weidman, chairman and chief executive officer. “We are transforming Celanese into an attractive, integrated hybrid portfolio of leading global businesses positioned to increase value and deliver sustainable growth.”
The sale includes oxo and derivatives businesses at Celanese’s Oberhausen, Germany, and Bay City, Texas facilities as well as portions of its Bishop, Texas, facility. The sale also includes EOXO’s facilities within the Oberhausen and Marl, Germany, plants, and the 50 percent interest in the EOXO joint venture previously owned by Degussa.
As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.7 billion in 2006, with over 60% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,900 employees worldwide. For more information on Celanese Corporation, please visit the company's website at www.celanese.com.
This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information.When used in this release, the words “outlook,”“forecast,” “estimates,”“expects,” “anticipates,”“projects,” “plans,”“intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements.Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.